Medical Technologies

Control Material for Quality Control of Qualitative Detection of Antibodies to Hepatitis B e Antigen in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers

Control Material for Quality Control of Qualitative Detection of Antibodies to Hepatitis B e Antigen in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers

Anti-HBe Negative Control

Option 1: 3 Vials

Control material for quality control of qualitative detection of antibodies to hepatitis B e antigen (Anti-HBe) in clinical samples using chemiluminescent immunoassay on CL series analyzers.

  • Vials: 3 x 2.0 mL
  • Contents:
    • Anti-HBe Negative Control, 2.0 mL – 3 vials
    • Control material value sheet
    • Instructions for use

Option 2: 6 Vials

Control material for quality control of qualitative detection of antibodies to hepatitis B e antigen (Anti-HBe) in clinical samples using chemiluminescent immunoassay on CL series analyzers.

  • Vials: 6 x 2.0 mL
  • Contents:
    • Anti-HBe Negative Control, 2.0 mL – 6 vials
    • Control material value sheet
    • Instructions for use

Anti-HBe Positive Control

Option 3: 3 Vials

Control material for quality control of qualitative detection of antibodies to hepatitis B e antigen (Anti-HBe) in clinical samples using chemiluminescent immunoassay on CL series analyzers.

  • Vials: 3 x 2.0 mL
  • Contents:
    • Anti-HBe Positive Control, 2.0 mL – 3 vials
    • Control material value sheet
    • Instructions for use

Option 4: 6 Vials

Control material for quality control of qualitative detection of antibodies to hepatitis B e antigen (Anti-HBe) in clinical samples using chemiluminescent immunoassay on CL series analyzers.

  • Vials: 6 x 2.0 mL
  • Contents:
    • Anti-HBe Positive Control, 2.0 mL – 6 vials
    • Control material value sheet
    • Instructions for use

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Control Material for Quality Control of Qualitative Detection of Antibodies to Hepatitis B e Antigen in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Copyright MAXXmarketing GmbH
JoomShopping Download & Support